- Home
- EXOZ vs CCIF Comparison
EXOZ vs CCIF Comparison
Compare EXOZ & CCIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXOZ
- CCIF
- Stock Information
- Founded
- EXOZ 2014
- CCIF 2011
- Country
- EXOZ United States
- CCIF United States
- Employees
- EXOZ N/A
- CCIF N/A
- Industry
- EXOZ
- CCIF Finance/Investors Services
- Sector
- EXOZ
- CCIF Finance
- Exchange
- EXOZ NYSE
- CCIF Nasdaq
- Market Cap
- EXOZ 138.0M
- CCIF 130.8M
- IPO Year
- EXOZ N/A
- CCIF N/A
- Fundamental
- Price
- EXOZ $10.47
- CCIF $6.46
- Analyst Decision
- EXOZ
- CCIF
- Analyst Count
- EXOZ 0
- CCIF 0
- Target Price
- EXOZ N/A
- CCIF N/A
- AVG Volume (30 Days)
- EXOZ 8.4K
- CCIF 76.9K
- Earning Date
- EXOZ 05-15-2025
- CCIF 01-01-0001
- Dividend Yield
- EXOZ N/A
- CCIF 25.90%
- EPS Growth
- EXOZ N/A
- CCIF N/A
- EPS
- EXOZ N/A
- CCIF N/A
- Revenue
- EXOZ N/A
- CCIF N/A
- Revenue This Year
- EXOZ N/A
- CCIF N/A
- Revenue Next Year
- EXOZ N/A
- CCIF N/A
- P/E Ratio
- EXOZ N/A
- CCIF N/A
- Revenue Growth
- EXOZ N/A
- CCIF N/A
- 52 Week Low
- EXOZ $8.50
- CCIF $7.43
- 52 Week High
- EXOZ $23.99
- CCIF $10.16
- Technical
- Relative Strength Index (RSI)
- EXOZ N/A
- CCIF 33.78
- Support Level
- EXOZ N/A
- CCIF $6.27
- Resistance Level
- EXOZ N/A
- CCIF $7.10
- Average True Range (ATR)
- EXOZ 0.00
- CCIF 0.36
- MACD
- EXOZ 0.00
- CCIF 0.01
- Stochastic Oscillator
- EXOZ 0.00
- CCIF 43.22
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
About CCIF Carlyle Credit Income Fund Shares of Beneficial Interest
Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.